Star Imaging And Path Lab Ltd (STARIMAGIN) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Star Imaging And Path Lab Ltd on NSE and BSE, with an AI summary of each filing.
Empanelment with Muncipal Corporation of Delhi (MCD)
Others (Uncategorized) · 12 Oct 2026, 11:51 pm
Star Imaging Empanelled With Municipal Corporation of Delhi for Diagnostic Services Star Imaging and Path Lab Limited has been empanelled with the Municipal Corporation of Delhi (MCD) to provide diagnostic services to eligible beneficiaries at CGHS-prescribed rates. The empanelment's validity is subject to the continuous validity of the company’s existing CGHS empanelment and related terms. This strategic development is expected to expand the company's operational reach and bolster its business volume in the diagnostic services segment across Delhi.
Voting Result and Scrutinizer report for the 22nd Annual General Meeting of Star Imaging and Path Lab Limited held on 29th September 2026.
Annual General Meeting · 30 Sept 2026, 11:45 pm
Summary of proceeding of 22nd Annual General Meeting (AGM) of Star Imaging and Path Lab Limited held on Tuesday 29th September 2026.
Annual General Meeting · 29 Sept 2026, 10:47 pm
CT Scan Facility at R G Stone Hospital Faridabad , Haryana
Others (Uncategorized) · 28 Sept 2026, 9:54 pm
Star Imaging Commences CT Scan Operations at Faridabad Hospital Tie-up Star Imaging and Path Lab Limited commenced commercial operations of a CT Scan diagnostic facility on 28th Sep'26 at R G Stone Urology & Laparoscopy Hospital in Faridabad, Haryana. The facility operates under a non-related party tie-up agreement with an initial tenure of 5 years, extendable by mutual consent. Geared toward expanding the company's regional diagnostic imaging network, the unit is slated to bolster service operations and revenues, although the precise financial impact remains unquantified at this stage.
Corrigendum to Notice and Annual Report for 22nd AGM for the FY 2025-26
Others (Uncategorized) · 04 Sept 2026, 6:23 pm
Compliance under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015
Annual Report · 01 Sept 2026, 8:09 pm
Notice of 22nd Annual General Meeting
Annual General Meeting · 01 Sept 2026, 7:59 pm
Annual Report of the Company for the financial year 2025-26 along with the Notice convening the 22nd Annual General Meeting ('AGM')
Others (Uncategorized) · 01 Sept 2026, 7:54 pm
Outcome of Board Meeting
Outcome · 28 Aug 2026, 10:26 pm
Star Imaging Board Approves AGM, Key Appointments Star Imaging and Path Lab's board approved its 22nd AGM to be held on 29th Sep'26. Key dates include a 24th Sep'26 e-voting cut-off, with the remote e-voting period from 26th Sep'26 to 28th Sep'26. The Board approved the MD&A for FY26 and recommended the re-appointment of Executive Director Ms. Neelam Ratra. It re-appointed M/s Sheetal & Co. as Secretarial Auditor and appointed Mr. Suraj Verma as the Internal Auditor, both for FY 2026-27, effective 28th Aug'26.
Outcome of the Board Meeting
Others (Uncategorized) · 28 Aug 2026, 9:38 pm
Star Imaging Board Approves AGM, Key Appointments, and FY26 Reports Star Imaging and Path Lab's board, in its meeting on 28 Aug'26, approved the 22nd Annual General Meeting to be held on 29 Sep'26. The board set the e-voting cut-off date as 24 Sep'26. Key approvals included the FY26 Board's Report and Management Discussion & Analysis. The board also re-appointed M/s Sheetal & Co. as Secretarial Auditor for FY27, appointed Mr. Suraj Verma as Internal Auditor for FY27, and recommended the re-appointment of Ms. Neelam Ratra as Executive Director.
Monitoring Agency Report for The Quarter ended 30th June 2026
Others (Uncategorized) · 13 Aug 2026, 9:33 pm
Star Imaging: IPO Proceeds Utilization Update for Q1FY27 As of 30th Jun'26, Star Imaging has utilized a total of ₹37.16 crore from its net IPO proceeds of ₹49.67 crore. During Q1FY27, the company spent ₹2.62 crore towards its working capital requirement. Unutilized funds of ₹12.51 crore remain, primarily allocated for ongoing working capital needs. These funds are temporarily parked in HDFC Bank sweep-in fixed deposits yielding 6.15% and a current account. The monitoring agency, Infomerics, reported no deviations from the stated objects of the issue.
Upgradation of Tilak Nagar Diagnostic Centre With Toshiba Aquilion ONE 1184 Slice/ Second CT Scanner
Others (Uncategorized) · 08 Jun 2026, 10:47 pm
Star Imaging Upgrades Tilak Nagar Centre with Advanced Toshiba CT Scanner Star Imaging and Path Lab Limited has upgraded its Tilak Nagar, New Delhi diagnostic centre by installing a Toshiba Aquilion ONE 1184 Slice/Second CT Scanner. The company disclosed this development on 08th Jun'26. This advanced system enhances diagnostic capabilities with superior speed, image quality, and whole-organ coverage (16 cm). The upgrade is expected to improve diagnostic outcomes, particularly in cardiac, neuro, and oncology imaging. This move reinforces the company's commitment to strengthening its healthcare infrastructure and service quality in North India.
Intimation of Availability of Text Transcript On Analysts / Institutional Investors / Organisations meet- Earnings Call.
Transcript · 27 May 2026, 10:17 pm
Intimation of the audio recording of Analysts / Institutional Investors / Organisations meet-Earnings Call
Audio / Video · 25 May 2026, 11:54 pm
Star Imaging Publishes Earnings Call Audio Recording for H2 & FY26 Results Star Imaging and Path Lab Limited has released the audio recording of its earnings call held on 25 May'26. The call discussed the audited standalone and consolidated financial results for the half-year and full financial year ended 31st March 2026. The recording is now available on the company's website for investors and analysts, as per SEBI disclosure requirements.
Investor Presentation for Half and Financial Year ended 31st March 2026
Investor Presentation · 25 May 2026, 4:57 pm
Star Imaging FY26 Results: Margin Expansion and B2C Growth Drive Performance Star Imaging reported strong FY26 performance with revenue up 6% YoY to ₹88.5 crores and PAT rising 20% YoY to ₹19.2 crores. EBITDA margin expanded significantly by 320 bps to 37.5%, driven by operating leverage. B2C revenue was a key growth driver, increasing 18% YoY to ₹33.0 crores. Cash flow from operations turned positive at ₹23.4 crores versus negative ₹2.6 crores in FY25. Management guides for 25-30% YoY growth, supported by network expansion, including a new center in Dwarka by H1 FY27.
Approved the Audited (Standalone and Consolidated ) Financial Statement for the Half and Year ended 31st March 2026
Financial Result · 22 May 2026, 10:10 pm
Star Imaging Reports FY26 Results with Unmodified Audit Opinion Star Imaging and Path Lab's Board approved the audited standalone and consolidated financial results for the half and full year ended 31 Mar'26. For FY26, standalone net profit was ₹1,931.60 lakhs on revenue of ₹8,852.69 lakhs, versus FY25 profit of ₹1,591.25 lakhs. Consolidated net profit for FY26 stood at ₹1,935.53 lakhs. Auditors issued an unmodified opinion. Of the ₹5,566.40 lakhs in IPO proceeds, ₹1,512.80 lakhs remains unutilized as of 31 Mar'26. The company operates solely in the "Diagnostic Services" segment.
Approved the Audited (Standalone and consolidated) financial results of the Company for the Half and Financial year ended 31 March 2026
Outcome · 22 May 2026, 10:03 pm
Star Imaging And Path Lab Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 4,334 (+5.9% YoY | -4.1% QoQ) ■ EBITDA: 1,589 (-5.9% YoY | -7.3% QoQ) ■ EBITDA Margin (%): 36.7 (-462 bps YoY | -125 bps QoQ) ■ PAT: 923 (-5.2% YoY | -8.0% QoQ) ■ EPS (INR): 5.30 (-5.2% YoY | -7.8% QoQ)
Intimation under Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015- Investor meet for the Half Year and Financial Year Ended March 31,2026
Intimation · 25 May 2026, 3:00 pm
Star Imaging Schedules H2 & FY26 Earnings Call for 25th May'26 Star Imaging and Path Lab Limited has scheduled an investor earnings call on Mon, 25th May'26, at 3:00 PM IST to discuss its financial results for the half-year and full-year ended 31st Mar'26. The company confirmed that no unpublished price-sensitive information will be disclosed. Key management, including Chairman & MD Mr. Pawan Gupta and CFO Mr. Azad Ali, will be present. The call will follow the company's board meeting on the same day.
Star Imaging And Path Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve Audited (Standalone ....
Intimation · 22 May 2026, 5:30 am
Star Imaging to Announce FY26 and H2FY26 Results on 22nd May Star Imaging and Path Lab Ltd has scheduled a Board of Directors meeting on 22nd May'26. The agenda includes the consideration and approval of the audited standalone and consolidated financial results for the half-year and full financial year ended 31st Mar'26. The trading window for insiders, which closed on 1st Apr'26, will reopen 48 hours after the results are declared. This meeting is a key event for assessing the company's full-year financial performance and growth trajectory.
Intimation for Appointment of Investor and Public Relations Agency- NeoAtlas Capital Advisor LLP
Others (Uncategorized) · 15 May 2026, 12:17 am
Star Imaging Appoints NeoAtlas Capital as Investor Relations Advisor Star Imaging and Path Lab Limited (STARIMAGIN) has appointed NeoAtlas Capital Advisory LLP as its Investor Relations and Strategic Communications Advisor, effective 14th May'26. This move is aimed at strengthening the company's investor engagement, enhancing transparency, and aligning its capital markets communication with institutional expectations. NeoAtlas Capital will support Star Imaging in its investor outreach and communication initiatives. The company's Scrip Code on BSE is 544482.
Monitoring Agency Report for the Quarter ended 31st March 2026
Others (Uncategorized) · 14 May 2026, 9:34 pm
Star Imaging: Monitoring Report on IPO Proceeds Utilization for Q4FY26 For Q4FY26, Star Imaging reported no deviation in utilizing its ₹49.67 crore net IPO proceeds. Out of the total, ₹34.54 crore has been utilized, with ₹5.14 crore spent during the quarter, primarily on purchasing refurbished medical equipment. A balance of ₹15.13 crore remains unutilized and is temporarily parked in bank fixed deposits and current accounts. The allocation for general corporate purposes was revised upwards to ₹7.53 crore from ₹6.93 crore due to lower-than-expected issue expenses. All project timelines are on schedule.
Annual Disclosure confirming non-applicability pertaining to fund raising by issuance of debt by Large entities
Others (Uncategorized) · 08 May 2026, 7:56 pm
Star Imaging Confirms Non-Applicability of Large Corporate Borrowing Framework Star Imaging and Path Lab Limited has formally notified the BSE on 08 May'26 that it does not qualify as a "Large Corporate" as of 31 Mar'26. Consequently, the company is not required to file the annual disclosure under Annexure B2 for the financial year 2026-27. This confirms that the mandatory fundraising requirements via debt securities, as stipulated by SEBI circulars for large entities, do not apply to the company. This disclosure clarifies its regulatory obligations concerning debt issuance.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 24 Apr 2026, 9:33 pm
Star Imaging Confirms It Is Not Classified as a Large Corporate Star Imaging and Path Lab Limited has formally notified the BSE that it does not qualify as a "Large Corporate" as per SEBI regulations, based on its status as of 31 Mar '26. Consequently, the company is exempt from the mandatory requirement to raise funds through the issuance of debt securities for the financial year 2026-27. This declaration confirms the non-applicability of SEBI's framework for large corporate borrowings. The filing was made on 24 Apr '26.
Clarification on Price Movement of Share
Others (Uncategorized) · 10 Apr 2026, 6:25 pm
Star Imaging Clarifies Share Price Movement, Cites Market Factors Star Imaging and Path Lab Limited (STARIMAGIN) on 10 Apr'26 responded to a BSE query regarding recent significant share price movement. The company confirmed it has disclosed all material information and events as per SEBI regulations and stated there is no pending undisclosed price-sensitive information. Management attributed the price volatility to market-driven factors, including general market conditions and speculative activities, over which it has no control. It also confirmed that Promoters and Key Managerial Personnel have not traded in the company's securities recently.
The Exchange has sought clarification from Star Imaging And Path Lab Ltd on April 9, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....
Others (Uncategorized) · 10 Apr 2026, 2:21 pm